Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

Sanofi branded clouded background image

Latest Articles

Metabolic Risk Factors and Effect of Alirocumab on CV Events

Metabolic Risk Factors and Effect of Alirocumab on CV Events

Managing the Recurrent ASCVD Risks of Your ACS Patient: A call to Action – GULF Perspective: Part 3

Managing Recurrent ASCVD risk of your ACS Patient: A call to Action – GULF Perspective: Part 2

Managing Recurrent ASCVD risk of your ACS Patient: A call to Action – GULF Perspective: Part 2

Managing the Recurrent ASCVD Risks of Your ACS Patient: Gulf Perspective (Part 1)

Managing the Recurrent ASCVD Risks of Your ACS Patient: Gulf Perspective (Part 1)

VTE prophylaxis in medically ill patients

Lipid management in patients with ACS/ASCVD

Improving Lipid Management for Patients Post-ACS

Identifying and treating patients with high Lipidaemia risk post-ACS

Atherosclerosis: Identifying risks and improving outcomes